AL-1095

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
AL-1095
AL-1095 structure.png
Systematic (IUPAC) name
2-(1-phenyl-1-(p-chlorophenyl)methyl)-3-hydroxyquinuclidine
Clinical data
Legal status
  • Unscheduled
Identifiers
CAS Number 54549-19-8 N
ATC code none
PubChem CID: 3041659
ChemSpider 2304906 YesY
Chemical data
Formula C20H22ClNO
Molecular mass 327.139 g/mol
  • OC(C1CCN2CC1)C2C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4
  • InChI=1S/C20H22ClNO/c21-17-8-6-15(7-9-17)18(14-4-2-1-3-5-14)19-20(23)16-10-12-22(19)13-11-16/h1-9,16,18-20,23H,10-13H2/t18?,19-,20+/m0/s1 YesY
  • Key:JXCMZYHEZWCLOD-NRRUETGQSA-N YesY
 NYesY (what is this?)  (verify)

AL-1095,[1] developed by Aldrich, is a centrally acting stimulant drug with comparable effects to amphetamine,[2] developed by Bristol in the 1970s.[3]

See also

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
  1. ↑ US Patent 3506673 -2-(4'HALO)-BENZHYDRYL-3-QUINUCLIDINOLS
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.
Retrieved from "https://infogalactic.com/w/index.php?title=AL-1095&oldid=4787208"